Could a sticky patch replace the dreaded sugar drink test for new moms?

NCT ID NCT07332416

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study is testing whether a continuous glucose monitor (CGM) worn on the arm for 14 days can replace the standard oral glucose tolerance test (OGTT) for women who had gestational diabetes. Many women find the OGTT burdensome and skip it, missing a chance to catch lingering blood sugar problems. The study will enroll 1,300 women 12-16 weeks after childbirth to see how many actually use and return the CGM sensor.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
continuous glucose monitor (Freestyle LibrePro)
What this could lead to
If successful, this could offer a simpler, more comfortable way to screen for diabetes after pregnancy, potentially improving follow-up care and long-term health.
What could go wrong
This is a pilot study focused on whether women will use the device, not on health outcomes. The CGM may not be as accurate as the standard test, and results may not apply to non-English speakers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Wake Forest University Health Sciences

    Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.